Factors associated with comprehensive medication review completion rates: A national survey of community pharmacists
- PMID: 31439525
- PMCID: PMC7543086
- DOI: 10.1016/j.sapharm.2019.08.008
Factors associated with comprehensive medication review completion rates: A national survey of community pharmacists
Abstract
Background: Completion rates for medication therapy management (MTM) services have been lower than desired and the Centers for Medicare and Medicaid Services has added MTM comprehensive medication review (CMR) completion rates as a Part D plan star measure. Over half of plans utilize community pharmacists via contracts with MTM vendors.
Objectives: The primary objective of this survey study was to identify factors associated with the CMR completion rates of community pharmacies contracted with a national MTM vendor.
Methodsl: Representatives from 27,560 pharmacy locations contracted with a national MTM vendor were surveyed. The dependent variable of interest was the pharmacies' CMR completion rate. Independent variables included the pharmacy's progressiveness stratum and number of CMRs assigned by the MTM vendor during the time period, as well as self-reported data to characterize MTM facilitators, barriers, delivery strategies, staffing, selected items from a modified Assessment of Chronic Illness Care, and pharmacist/pharmacy demographics. Univariate negative binomial models were fit for each independent variable, and variables significant at p < 0.05 were entered into a multivariable model.
Results: Representatives from 3836 (13.9%) pharmacy locations responded; of these, 90.9% (n = 3486) responses were useable. The median CMR completion rate was 0.42. Variables remaining significant at p < 0.05 in the multivariable model included: progressiveness strata; pharmacy type; scores on the facilitators scale; responses to two potential barriers items; scores on the patient/caregiver delivery strategies sub-scale; providing MTM at multiple locations; reporting that the MTM vendor sending the survey link is the primary MTM vendor for which the respondent provides MTM; and the number of hours per week that the pharmacy is open.
Conclusions: Factors at the respondent (e.g., responses to facilitators scale) and pharmacy (e.g., pharmacy type) levels were associated with CMR completion rates. These findings could be used by MTM stakeholders to improve CMR completion rates.
Keywords: Community pharmacy services; Health care surveys; Medicare; Medication therapy management.
Copyright © 2019 Elsevier Inc. All rights reserved.
Similar articles
-
What predicts medication therapy management completion rates? The role of community pharmacy staff characteristics and beliefs about medication therapy management.J Am Pharm Assoc (2003). 2018 Jul-Aug;58(4S):S7-S15.e5. doi: 10.1016/j.japh.2018.03.001. Epub 2018 May 3. J Am Pharm Assoc (2003). 2018. PMID: 29731422
-
Positive deviants for medication therapy management: A mixed-methods comparative case study of community pharmacy practices.Res Social Adm Pharm. 2021 Aug;17(8):1407-1419. doi: 10.1016/j.sapharm.2020.10.006. Epub 2020 Oct 28. Res Social Adm Pharm. 2021. PMID: 33214124 Free PMC article.
-
Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.J Manag Care Pharm. 2009 Jan-Feb;15(1):18-31. doi: 10.18553/jmcp.2009.15.1.18. J Manag Care Pharm. 2009. PMID: 19125547 Free PMC article.
-
Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.J Manag Care Pharm. 2011 Apr;17(3):213-23. doi: 10.18553/jmcp.2011.17.3.213. J Manag Care Pharm. 2011. PMID: 21434698 Free PMC article.
-
Review of survey articles regarding medication therapy management (MTM) services/programs in the United States.J Pharm Pract. 2012 Aug;25(4):457-70. doi: 10.1177/0897190012442715. J Pharm Pract. 2012. PMID: 22544620 Review.
Cited by
-
Development, Pilot, and Evaluation of a Qualitative Documentation Tool for Pharmacists to Share High Impact Patient Intervention Stories.Innov Pharm. 2024 Aug 21;15(3):10.24926/iip.v15i3.5772. doi: 10.24926/iip.v15i3.5772. eCollection 2024. Innov Pharm. 2024. PMID: 39483506 Free PMC article.
-
Moving Deprescribing Upstream.J Gen Intern Med. 2022 Sep;37(12):3176-3177. doi: 10.1007/s11606-022-07537-x. Epub 2022 Apr 11. J Gen Intern Med. 2022. PMID: 35411528 Free PMC article. No abstract available.
-
Effects of the Medicare Part D Comprehensive Medication Review on Racial and Ethnic Disparities in Medication Adherence.Am Health Drug Benefits. 2021 Sep;14(3):101-109. Am Health Drug Benefits. 2021. PMID: 35261713 Free PMC article.
-
Pharmacists' Experiences, Perceptions, and Knowledge of Direct-to-Consumer Prescription Coupons.J Manag Care Spec Pharm. 2020 Sep;26(9):1130-1137. doi: 10.18553/jmcp.2020.26.9.1130. J Manag Care Spec Pharm. 2020. PMID: 32857654 Free PMC article.
-
Community pharmacists' exposure to COVID-19.Res Social Adm Pharm. 2021 Jan;17(1):1882-1887. doi: 10.1016/j.sapharm.2020.05.020. Epub 2020 May 27. Res Social Adm Pharm. 2021. PMID: 32499159 Free PMC article.
References
-
- Centers for Medicare and Medicaid Services (CMS) HHS. Medicare program; Medicare Prescription Drug Benefit, Final Rule. Federal Register. 2005;70:4193–4585. - PubMed
-
- Cubanski J, Damico A, Neuman T. Medicare Part D in 2018: The latest on enrollment, premiums, and cost sharing. Available at: https://www.kff.org/medicare/issue-brief/medicare-part-d-in-2018-the-lat.... Accessed April 8, 2019.
-
- Kaiser Family Foundation. 10 Essential Facts about Medicare and Prescription Drug Spending. November 10, 2017. Available at: https://www.kff.org/infographic/10-essential-facts-about-medicare-and-pr.... Accessed April 8, 2019.
-
- “Memo Contract Year 2019 Medication Therapy Management (MTM) Program Submission.” Centers for Medicare and Medicaid Services (CMS). Available at: https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrug.... Accessed April 8, 2019.
-
- Brandt NJ, Cooke CE. Centers for Medicare and Medicaid Services Support for Medication Therapy Management (Enhanced Medication Therapy Management): Testing strategies for improving medication use among beneficiaries enrolled in Medicare Part D. Clin Geriatr Med. 2017;33:153–64. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
